Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

98.44 +0.65 (+0.67%)
Delayed Quote Updated: 1:27 PM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insmed Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Insmed: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Insmed's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
A Preview Of Insmed's Earnings ↗
 
Via Benzinga
News headline image
Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum
From Emerald Asset Management PA, LLC
Via Business Wire
News headline image
Barclays Maintains Overweight Rating for Insmed: Here's What You Need To Know ↗
 
Via Benzinga
Analyst Expectations for Insmed's Future ↗
 
Via Benzinga
Analyst Ratings for Insmed ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Insmed ↗
 
Via Benzinga
News headline image
Why Insmed's Shares Fell 14.7% on Wednesday ↗
The biotech company is raising money to help it launch another drug, but it's diluting current shareholders in the process. 
Via The Motley Fool
News headline image
Insmed's Return On Capital Employed Insights ↗
  
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Insmed: Q1 Earnings Insights ↗
Insmed (NASDAQ:INSM) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Insmed: Q4 Earnings Insights ↗
  Insmed (NASDAQ:INSM) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Insmed's Return On Capital Employed Overview ↗
Benzinga Pro data, Insmed (NASDAQ:INSM) reported Q3 sales of $67.73 million. Earnings fell to a loss of $131.15 million, resulting in a 37.12% decrease from last quarter. 
Via Benzinga
News headline image
$1.4 Million Bet On This Real Estate Stock? 3 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Insmed: Q3 Earnings Insights ↗
Insmed (NASDAQ:INSM) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Insmed missed estimated earnings by... 
Via Benzinga
News headline image
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday ↗
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... 
Via Benzinga
News headline image
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. 
Via Benzinga
News headline image
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday ↗
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
Insmed's Return On Capital Employed Overview ↗
According to data from Benzinga Pro, during Q1, Insmed's (NASDAQ:INSM) reported sales totaled $53.11 million. Despite a 16.25% increase in earnings, the company posted a loss of $94.62 million. 
Via Benzinga
News headline image
How To Attend Insmed Q1 2022 Earnings Conference Call ↗
Insmed (NASDAQ:INSM) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Insmed (INSM) Conference Call Follow this link to access the live... 
Via Benzinga
News headline image
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday ↗
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... 
Via Benzinga
News headline image
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. 
Via Benzinga
News headline image
Insmed's Return On Capital Employed Insights ↗
Insmed (NASDAQ:INSM) brought in sales totaling $56.12 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 0.23%, resulting in a loss of $112.98 million. 
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.